HHS Launched AI Initiative for Clinical Trials
The government created the SURPASS program to accelerate the clinical trial process using artificial intelligence.
Updated on Sept. 30, 2026 in Artificial Intelligence
Live Poll
Do you trust that incorporating artificial intelligence will improve the accuracy of clinical medical trials?
The Department of Health and Human Services has unveiled the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. Managed by the Advanced Research Projects Agency for Health, this initiative seeks to modernize medical research by integrating AI.
Why it matters
The program aims to drastically reduce the time required for clinical trials by shifting away from traditional, delineated trial phases. This integration of computational models represents a significant change in how health research is conducted at the federal level.
The SURPASS program will utilize advanced computational models to replace traditional, sequential trial phases over a five-year period. It is designed to foster collaboration among cross-disciplinary teams in artificial intelligence, statistics, and clinical trial design.
The players
Department of Health and Human Services
This is the United States federal department responsible for protecting the health of all Americans and providing essential human services.
Advanced Research Projects Agency for Health
This agency is tasked with accelerating biomedical innovation by funding high-potential, high-impact research projects.
The details
The program invites proposals from teams to create systems that utilize real-time data to streamline research. By moving away from rigid, multi-phase structures, the agency hopes to increase the efficiency of clinical discovery.
Timeline
The program is set to officially kick off in the fall of 2026.
The Tech Race
This program marks a departure from traditional, phase-based medical testing by favoring adaptive, AI-driven platforms. It signals an effort to keep pace with global advancements in computational biology and automated data analysis.
For patients and healthcare providers, this initiative could eventually lead to faster access to innovative treatments and new medications. If successful, the program will shorten the lifecycle of clinical research, reducing the wait time for breakthrough medical breakthroughs.
The takeaway
The move suggests a long-term shift toward automated and adaptive research methods that prioritize speed and efficiency. Researchers and tech developers should monitor future agency solicitations for opportunities to contribute to these new computational platforms.
Further reading
Learn more about federal developments in Artificial Intelligence.
Live Poll
Do you trust that incorporating artificial intelligence will improve the accuracy of clinical medical trials?
